EQS-News: Organicell Regenerative Medicine, Inc. Starts Enrolling Long COVID Trial

EQS-News: Organicell Regenerative Medicine, Inc.
OTCMKTS: OCEL - Organicell Starts Enrolling Long COVID Trial

22.11.2022 / 17:33 CET/CEST
The issuer is solely responsible for the content of this announcement.

---

Contact Details

Organicell Investor Relations

[e-mail]

Company Website

https://organicell.com/

News Source: News Direct

---

22.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	Organicell Regenerative Medicine, Inc.
	United States
ISIN:	US68621D1072
EQS News ID:	1494035

End of News	EQS News Service

---

1494035 22.11.2022 CET/CEST